Research is one of the main pillars of the Post-COVID-19 Interdisciplinary Clinical Care Network (PC-ICCN).
The Network coordinates patient-oriented research that leads to rapid learning and data-sharing to improve care. Our researchers represent diverse areas of health-care expertise and are actively doing research to support communities throughout B.C. and Canada.
Research is a critical component of delivering optimum, patient-centered care; that’s why the Post-COVID-19 Interdisciplinary Clinical Care Network is looking to support researchers studying long COVID. Throughout the pandemic, thousands of patients have been registered for support with the PC-ICCN. The Network has been collecting data from all of these patients to support care and to learn more about long COVID.
If you are a researcher who is looking to contribute to patient-centered research, email
post-covid-research@phsa.ca or complete our research intake form.
Research Intake Form (PDF)
We look forward to updating our patient partners on research opportunities. An introductory video on the Naltrexone Study for Post-COVID Fatigue Syndrome is coming soon.
To complement its clinically-based research efforts, PC-ICCN is a partner in the Long COVID Patient Experience Project (
https://patientscientist.ca). The Long COVID Patient Experience Project was developed to connect people living with long COVID and health researchers to learn together about the impacts of long COVID.
The Post-COVID Interdisciplinary Clinical Care Network is supporting the project by reviewing proposals from researcher(s) who want to access the data collected through the Project. Researchers with questions about their research proposals related to the Long COVID Patient Experience Project should contact
CitizenScience@arthritisresearch.ca.
-
Long COVID research receives $20 million investment by CIHR: Dr. Adeera Levin, the provincial lead of PC-ICCN, is one of four co-leads on a new pan-Canadian Post COVID-19 Condition Research Network called
Long COVID Web. This project, supported by $20 million from the Canadian Institutes of Health Research, aims to develop diagnostics, treatments, and rehabilitation strategies for all forms of long COVID. This work will inform evidence-based and standardized clinical practices aimed at reducing the socioeconomic impact of this disability.
Read the full news release.
- Congratulations to the research team (Erin Cooke, Travis Boulter, Melody Tsai and Dr. Luis Nacul) for obtaining Health Canada approval for the "Naltrexone Study for Post-COVID fatigue Syndrome".
- Congratulations to Dr. Hiten Naik who was awarded a UBC Clinician Investigator Program fellowship. Dr. Naik is working closely with the Post-COVID Interdisciplinary Clinical Care Network team to support long COVID research.
